Pharsight

HIGHLIGHT THERAPEUTICS SL PATENTS FACING OPPOSITIONS

Top patents of HIGHLIGHT THERAPEUTICS SL facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3319587B1 21 Aug, 2019 Novel Pharmaceutical Composition Comprising Particles Comprising A Complex Of A Double-Stranded Polyribonucleotide And A Polyalkyleneimine NA 1